Given that the expression of NRF2 is also downregulated in various models of Alzheimer's disease, SCA, and Parkinson's disease [30–35], further studies will be necessary to explore the neuroprotective potentials and molecular mechanisms of NC001-8 in other neurodegenerative diseases. This evidence concerns the gene NFE2L2 and Alzheimer disease.